Technical Analysis for NBRV - Nabriva Therapeutics AG

Grade Last Price % Change Price Change
grade F 0.7349 -9.27% -0.08
NBRV closed down 9.27 percent on Friday, August 7, 2020, on 35 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical NBRV trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Earnings Movers Other -9.27%
Inside Day Range Contraction -9.27%
Wide Bands Range Expansion -9.27%
50 DMA Support Bullish -10.99%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It also develops BC-7013, a topical pleuromutilin antibiotic, which has completed a Phase 1 clinical trial. Nabriva Therapeutics AG is based in Vienna, Austria.
Chemistry Pharmaceutical Industry Chemical Compounds Organic Compounds Antibiotics Alcohols Antibiotic Infections Pneumonia Skin And Skin Structure Infections Community Acquired Bacterial Pneumonia

Is NBRV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.77
52 Week Low 0.485
Average Volume 11,209,681
200-Day Moving Average 1.13
50-Day Moving Average 0.78
20-Day Moving Average 0.79
10-Day Moving Average 0.79
Average True Range 0.07
ADX 25.08
+DI 30.02
-DI 22.72
Chandelier Exit (Long, 3 ATRs ) 0.94
Chandelier Exit (Short, 3 ATRs ) 0.81
Upper Bollinger Band 0.92
Lower Bollinger Band 0.65
Percent B (%b) 0.3
BandWidth 33.89
MACD Line 0.01
MACD Signal Line 0.01
MACD Histogram -0.0046
Fundamentals Value
Market Cap 19.72 Million
Num Shares 26.8 Million
EPS -11.49
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 24.71
Price-to-Book 3.00
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.81
Resistance 3 (R3) 0.81 0.79 0.80
Resistance 2 (R2) 0.79 0.77 0.79 0.79
Resistance 1 (R1) 0.76 0.76 0.75 0.76 0.79
Pivot Point 0.74 0.74 0.74 0.74 0.74
Support 1 (S1) 0.71 0.72 0.70 0.71 0.68
Support 2 (S2) 0.69 0.71 0.69 0.68
Support 3 (S3) 0.66 0.69 0.67
Support 4 (S4) 0.66